Kinney Horn
Corporate Officer/Principal at IMMUNOME, INC.
Net worth: 27 825 $ as of 31/03/2024
Profile
Mr. Kinney Horn is a Chief Business Officer at Immunome, Inc. Mr. Horn was previously employed as a Chief Business Officer by Olema Pharmaceuticals, Inc. and a Director-Business Development by Genentech, Inc. He received his undergraduate degree from the University of Mary Washington and a graduate degree from Georgetown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/02/2023 | 2,458 ( 0.00% ) | 27 825 $ | 31/03/2024 |
Kinney Horn active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 01/02/2024 |
Former positions of Kinney Horn
| Companies | Position | End |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24/03/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2019 |
Training of Kinney Horn
| Georgetown University | Graduate Degree |
| University of Mary Washington | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Kinney Horn
